Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities

NCT06997198 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Tardive Dyskinesia
Intellectual Disability
Developmental Disabilities

Interventions

DRUG: Deutetrabenazine Oral Capsule

Sponsor

University Hospitals Cleveland Medical Center

Collaborators

[object Object]